The Criteria to Confirm the Role of Epstein-Barr Virus in Nasopharyngeal Carcinoma Initiation

by Ai-Di Gu, Mu-Sheng Zeng, Chao-Nan Qian
Published 2012-10-01

The Status and Prospects of Epstein–Barr Virus Prophylactic Vaccine Development

by Cong Sun, Xin-chun Chen, Yin-feng Kang, Mu-sheng Zeng
Published 2021-06-01

TRIM29 promotes DNA virus infections by inhibiting innate immune response

by Junji Xing, Ao Zhang, Hua Zhang, Jin Wang, Xian Chang Li, Mu-Sheng Zeng, Zhiqiang Zhang
Published 2017-10-01

Down-regulation of c9orf86 in human breast cancer cells inhibits cell proliferation, invasion and tumor growth and correlates with survival of breast cancer patients.

by Yang-Yang Li, Sha Fu, Xiao-Pai Wang, Hai-Yun Wang, Mu-Sheng Zeng, Jian-Yong Shao
Published 2013-01-01

A method to establish a c-Myc transgenic mouse model of hepatocellular carcinoma

by Yan Mei, Chao Zhou, Chao-Yong Liang, Guan-Ming Lu, Mu-Sheng Zeng, Jin-Jin Wang, Guo-Kai Feng
Published 2020-01-01

Advances in pathogenesis and precision medicine for nasopharyngeal carcinoma

by Qian‐Ying Zhu, Ge‐Xin Zhao, Yan Li, Girish Talakatta, Hai‐Qiang Mai, Quynh‐Thu Le, Lawrence S. Young, Mu‐Sheng Zeng
Published 2021-06-01

Knockdown of miR-214 promotes apoptosis and inhibits cell proliferation in nasopharyngeal carcinoma.

by Zi-Chen Zhang, Yang-Yang Li, Hai-Yun Wang, Sha Fu, Xiao-Pai Wang, Mu-Sheng Zeng, Yi-Xin Zeng, Jian-Yong Shao
Published 2014-01-01

Bullatacin Triggered ABCB1-Overexpressing Cell Apoptosis via the Mitochondrial-Dependent Pathway

by Yong-Ju Liang, Xu Zhang, Chun-Ling Dai, Jian-Ye Zhang, Yan-Yan Yan, Mu-Sheng Zeng, Li-Ming Chen, Li-Wu Fu
Published 2009-01-01

The pretreatment albumin to globulin ratio has predictive value for long-term mortality in nasopharyngeal carcinoma.

by Xiao-Jing Du, Ling-Long Tang, Yan-Ping Mao, Ying Sun, Mu-Sheng Zeng, Tie-Bang Kang, Wei-Hua Jia, Ai-Hua Lin, Jun Ma
Published 2014-01-01

Adaptor protein LNK promotes anaplastic thyroid carcinoma cell growth via 14-3-3 ε/γ binding

by Zhao-Ming Zhong, Xue Chen, Xiao Qi, Xue-Min Wang, Chun-Yan Li, Ru-Jia Qin, Shi-Qi Wang, Jin Liang, Mu-Sheng Zeng, Chuan-Zheng Sun
Published 2020-01-01

PD-1+CXCR5−CD4+ Th-CXCL13 cell subset drives B cells into tertiary lymphoid structures of nasopharyngeal carcinoma

by Shu-Mei Yan, Jiang-Ping Li, Chang-You Wu, Ming-Yuan Chen, Shang-Xin Liu, Yin-Feng Kang, Cong Sun, Jennifer R Grandis, Mu-Sheng Zeng, Qian Zhong
Published 2021-07-01

Decreased expression of SATB2: a novel independent prognostic marker of worse outcome in laryngeal carcinoma patients.

by Tian-Run Liu, Li-Hua Xu, An-Kui Yang, Qian Zhong, Ming Song, Man-Zhi Li, Li-Juan Hu, Fu-Jin Chen, Ze-Dong Hu, Ping Han, Mu-Sheng Zeng
Published 2012-01-01

Structure of Epstein-Barr virus tegument protein complex BBRF2-BSRF1 reveals its potential role in viral envelopment

by Hui-Ping He, Meng Luo, Yu-Lu Cao, Yu-Xin Lin, Hua Zhang, Xiao Zhang, Jun-Ying Ou, Bing Yu, Xiaoxue Chen, Miao Xu, Lin Feng, Mu-Sheng Zeng, Yi-Xin Zeng, Song Gao
Published 2020-10-01

Vasculogenic mimicry formation in EBV-associated epithelial malignancies

by Tong Xiang, Yu-Xin Lin, Wenlong Ma, Hao-Jiong Zhang, Ke-Ming Chen, Gui-Ping He, Xiao Zhang, Miao Xu, Qi-Sheng Feng, Ming-Yuan Chen, Mu-Sheng Zeng, Yi-Xin Zeng, Lin Feng
Published 2018-11-01

Epstein-Barr virus activates F-box protein FBXO2 to limit viral infectivity by targeting glycoprotein B for degradation.

by Hao-Jiong Zhang, Jinxiu Tian, Xue-Kang Qi, Tong Xiang, Gui-Ping He, Hua Zhang, Xibao Yu, Xiao Zhang, Bingchun Zhao, Qi-Sheng Feng, Ming-Yuan Chen, Mu-Sheng Zeng, Yi-Xin Zeng, Lin Feng
Published 2018-07-01

Different prognostic values of plasma Epstein-Barr virus DNA and maximal standardized uptake value of 18F-FDG PET/CT for nasopharyngeal carcinoma patients with recurrence.

by Ting Shen, Lin-Quan Tang, Dong-Hua Luo, Qiu-Yan Chen, Pei-Jing Li, Dong-Mei Mai, Shan-Shan Guo, Li-Ting Liu, Chao-Nan Qian, Xiang Guo, Mu-Sheng Zeng, Hao-Yuan Mo, Hai-Qiang Mai
Published 2015-01-01

Comparison of long-term survival and toxicity of cisplatin delivered weekly versus every three weeks concurrently with intensity-modulated radiotherapy in nasopharyngeal carcinoma.

by Chang-Juan Tao, Li Lin, Guan-Qun Zhou, Ling-Long Tang, Lei Chen, Yan-Ping Mao, Mu-Sheng Zeng, Tie-Bang Kang, Wei-Hua Jia, Jian-Yong Shao, Hai-Qiang Mai, Ai-Hua Lin, Jun Ma, Ying Sun
Published 2014-01-01

Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapy.

by Jiang Li, Xue-hui Zeng, Hao-yuan Mo, Ulrika Rolén, Yan-fang Gao, Xiao-shi Zhang, Qiu-yan Chen, Li Zhang, Mu-sheng Zeng, Man-zhi Li, Wen-lin Huang, Xiao-ning Wang, Yi-xin Zeng, Maria G Masucci
Published 2007-11-01

Plasma Epstein-Barr Virus-Deoxyribonucleic Acid Copy Number Predicts Disease Progression in Stage I–III Pulmonary Lymphoepithelioma-Like Carcinoma

by Qi-Wen Li, Bo Qiu, Wan-Ming Hu, Su-Ping Guo, Ying-Jia Wu, Yu-Jia Zhu, Nan Hu, Xin-Lei Ai, Nai-Bin Chen, Jin-Yu Guo, Yong-Hong Hu, Meng-Zhong Liu, Mu-Sheng Zeng, Hui Liu
Published 2020-08-01

Is Hemoglobin Level in Patients with Nasopharyngeal Carcinoma Still a Significant Prognostic Factor in the Era of Intensity-Modulated Radiotherapy Technology?

by Shan-Shan Guo, Lin-Quan Tang, Qiu-Yan Chen, Lu Zhang, Li-Ting Liu, Pei-Yu Huang, Ka-Jia Cao, Ling Guo, Hao-Yuan Mo, Xiang Guo, Ming-Huang Hong, Mu-Sheng Zeng, Chao-Nan Qian, Hai-Qiang Mai
Published 2015-01-01